focus -WSS

focus

author：focus 2025-09-06 04:35:56 - browse：7577

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： A new initiative will help leaders fight the next pandemic

leisure time

WSS

What happened to the House vote on health price transparency?

FDA panel to weigh safety of artificial wombs for preterm births

Transgender sports debate: Physicians say bans are health issue

FDA panel to weigh safety of artificial wombs for preterm births

Structure Therapeutics oral GLP

Information blocking fines are now fair game in health care

focus

focus

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Eli Lilly CEO gives to Mike Pence presidential super PAC

At least 13 dead in Texas as scorching temps continue

FTC loses bid to block Novant's North Carolina hospital merger

As demand for Covid shots wanes, Moderna seeks its next success

Eli Lilly CEO gives to Mike Pence presidential super PAC

Wildfire smoke exposes gaps in outdoor worker protections

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA panel to weigh safety of artificial wombs for preterm births

explore

The unintended consequences of overturning Roe v. Wade

BD to buy Edwards patient monitoring unit for $4.2 billion

BD to buy Edwards patient monitoring unit for $4.2 billion

Why the quest to eradicate polio has stumbled

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Medicare to pay more for cardiac rehab in hospital outpatient clinics

hotspot

hotspot

leisure time

Wikipedia